Monday, July 22, 2024 11:58:32 AM
THANK YOU, MIRA
Recent MIRA News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/27/2024 09:20:15 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/27/2024 08:45:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 08:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 08:01:33 PM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 09/06/2024 08:38:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2024 12:20:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 08:05:09 PM
- IBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without Astronauts • IH Market News • 08/26/2024 12:58:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 08:15:12 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/16/2024 08:05:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:06:29 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/12/2024 12:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:13:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:54:37 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/26/2024 08:55:26 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/26/2024 08:49:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 08:07:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 09:12:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 09:00:40 PM
- MIRA Pharmaceuticals Announces Ketamir-2 Shows Promising Safety Profile in Comparison to Traditional Ketamine In Preclinical Testing • PR Newswire (US) • 06/24/2024 12:30:00 PM
- Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year • PR Newswire (US) • 06/10/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 10:00:06 PM
- Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance • PR Newswire (US) • 05/29/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 12:30:38 PM
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM